APO Research

APO RESEARCH · REPORT

Aquaporin

Selected research

Market Analysis & Forecast

Global Aquaporin Market Analysis and Forecast 2026-2032

Market perspective

The global Aquaporin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Aquaporin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Aquaporin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Aquaporin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Aquaporin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Aquaporin include Merck KGaA, Santa Cruz Biotechnology, Proteintech Group, Boster Biological Technology, Bio-Techne, Bio-Rad Laboratories, Alomone Labs, Abcam and Abbexa, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Aquaporin, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Aquaporin, also provides the revenue of main regions and countries. Of the upcoming market potential for Aquaporin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Aquaporin revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Aquaporin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Aquaporin revenue, projected growth trends, production technology, application and end-user industry.

Aquaporin Segment by Company

Merck KGaA

Santa Cruz Biotechnology

Proteintech Group

Boster Biological Technology

Bio-Techne

Bio-Rad Laboratories

Alomone Labs

Abcam

Abbexa

Aquaporin Segment by Type

Anti-Aquaporin Antibody

Aquaporin Channel Blocker

Other

Aquaporin Segment by Application

Purification Of Water

Research

Medicine

Other

Aquaporin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aquaporin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aquaporin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aquaporin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Aquaporin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Aquaporin company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aquaporin revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Aquaporin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Anti-Aquaporin Antibody Major Player Table 3. Aquaporin Channel Blocker Major Player Table 4. Other Major Player Table 5. Global Aquaporin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Purification Of Water Major Player Table 7. Research Major Player Table 8. Medicine Major Player Table 9. Other Major Player Table 10. Aquaporin Industry Trends Table 11. Aquaporin Industry Drivers Table 12. Aquaporin Industry Opportunities and Challenges Table 13. Aquaporin Industry Restraints Table 14. Global Aquaporin Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Aquaporin Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Aquaporin Market Share by Region (2021-2026) Table 17. Global Aquaporin Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Aquaporin Market Share by Region (2027-2032) Table 19. Global Aquaporin Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Aquaporin Revenue Market Share by Players (2021-2026) Table 21. Global Aquaporin Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Aquaporin Key Players Headquarters & Area Served Table 23. Global Aquaporin Players, Product Type & Application Table 24. Global Aquaporin Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Aquaporin by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Aquaporin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Aquaporin Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Aquaporin Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Aquaporin Revenue Market Share by Type (2021-2026) Table 31. Global Aquaporin Revenue Market Share by Type (2027-2032) Table 32. Global Aquaporin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Aquaporin Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Aquaporin Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Aquaporin Revenue Market Share by Application (2021-2026) Table 36. Global Aquaporin Revenue Market Share by Application (2027-2032) Table 37. Merck KGaA Company Information Table 38. Merck KGaA Business Overview Table 39. Merck KGaA Aquaporin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Merck KGaA Aquaporin Product Portfolio Table 41. Merck KGaA Recent Development Table 42. Santa Cruz Biotechnology Company Information Table 43. Santa Cruz Biotechnology Business Overview Table 44. Santa Cruz Biotechnology Aquaporin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Santa Cruz Biotechnology Aquaporin Product Portfolio Table 46. Santa Cruz Biotechnology Recent Development Table 47. Proteintech Group Company Information Table 48. Proteintech Group Business Overview Table 49. Proteintech Group Aquaporin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Proteintech Group Aquaporin Product Portfolio Table 51. Proteintech Group Recent Development Table 52. Boster Biological Technology Company Information Table 53. Boster Biological Technology Business Overview Table 54. Boster Biological Technology Aquaporin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Boster Biological Technology Aquaporin Product Portfolio Table 56. Boster Biological Technology Recent Development Table 57. Bio-Techne Company Information Table 58. Bio-Techne Business Overview Table 59. Bio-Techne Aquaporin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Bio-Techne Aquaporin Product Portfolio Table 61. Bio-Techne Recent Development Table 62. Bio-Rad Laboratories Company Information Table 63. Bio-Rad Laboratories Business Overview Table 64. Bio-Rad Laboratories Aquaporin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Bio-Rad Laboratories Aquaporin Product Portfolio Table 66. Bio-Rad Laboratories Recent Development Table 67. Alomone Labs Company Information Table 68. Alomone Labs Business Overview Table 69. Alomone Labs Aquaporin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Alomone Labs Aquaporin Product Portfolio Table 71. Alomone Labs Recent Development Table 72. Abcam Company Information Table 73. Abcam Business Overview Table 74. Abcam Aquaporin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Abcam Aquaporin Product Portfolio Table 76. Abcam Recent Development Table 77. Abbexa Company Information Table 78. Abbexa Business Overview Table 79. Abbexa Aquaporin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Abbexa Aquaporin Product Portfolio Table 81. Abbexa Recent Development Table 82. North America Aquaporin Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Aquaporin Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Aquaporin Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Aquaporin Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Aquaporin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Aquaporin Revenue by Country (2021-2026) & (US$ Million) Table 88. North America Aquaporin Revenue by Country (US$ Million) & (2027-2032) Table 89. Europe Aquaporin Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Aquaporin Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Aquaporin Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Aquaporin Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Aquaporin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe Aquaporin Revenue by Country (2021-2026) & (US$ Million) Table 95. Europe Aquaporin Revenue by Country (US$ Million) & (2027-2032) Table 96. China Aquaporin Revenue by Type (2021-2026) & (US$ Million) Table 97. China Aquaporin Revenue by Type (2027-2032) & (US$ Million) Table 98. China Aquaporin Revenue by Application (2021-2026) & (US$ Million) Table 99. China Aquaporin Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia Aquaporin Revenue by Type (2021-2026) & (US$ Million) Table 101. Asia Aquaporin Revenue by Type (2027-2032) & (US$ Million) Table 102. Asia Aquaporin Revenue by Application (2021-2026) & (US$ Million) Table 103. Asia Aquaporin Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Aquaporin Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia Aquaporin Revenue by Region (US$ Million) & (2021-2026) Table 106. Asia Aquaporin Revenue by Region (US$ Million) & (2027-2032) Table 107. SAMEA Aquaporin Revenue by Type (2021-2026) & (US$ Million) Table 108. SAMEA Aquaporin Revenue by Type (2027-2032) & (US$ Million) Table 109. SAMEA Aquaporin Revenue by Application (2021-2026) & (US$ Million) Table 110. SAMEA Aquaporin Revenue by Application (2027-2032) & (US$ Million) Table 111. SAMEA Aquaporin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. SAMEA Aquaporin Revenue by Country (2021-2026) & (US$ Million) Table 113. SAMEA Aquaporin Revenue by Country (US$ Million) & (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Aquaporin Image Figure 2. Global Aquaporin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aquaporin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Anti-Aquaporin Antibody Image Figure 5. Aquaporin Channel Blocker Image Figure 6. Other Image Figure 7. Global Aquaporin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Aquaporin Market Size Share 2021 VS 2025 VS 2032 Figure 9. Purification Of Water Image Figure 10. Research Image Figure 11. Medicine Image Figure 12. Other Image Figure 13. Global Aquaporin Market Size (US$ Million) & (2021-2032) Figure 14. Global Aquaporin Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Aquaporin Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Aquaporin Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Aquaporin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Aquaporin Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Aquaporin Revenue Market Share by Type (2021-2032) Figure 21. Global Aquaporin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Aquaporin Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Aquaporin Revenue Market Share by Application (2021-2032) Figure 24. North America Aquaporin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Aquaporin Revenue Share by Type (2021-2032) Figure 26. North America Aquaporin Revenue Share by Application (2021-2032) Figure 27. North America Aquaporin Revenue Share by Country (2021-2032) Figure 28. United States Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Aquaporin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Aquaporin Revenue Share by Type (2021-2032) Figure 33. Europe Aquaporin Revenue Share by Application (2021-2032) Figure 34. Europe Aquaporin Revenue Share by Country (2021-2032) Figure 35. Germany Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Aquaporin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Aquaporin Revenue Share by Type (2021-2032) Figure 45. China Aquaporin Revenue Share by Application (2021-2032) Figure 46. Asia Aquaporin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Aquaporin Revenue Share by Type (2021-2032) Figure 48. Asia Aquaporin Revenue Share by Application (2021-2032) Figure 49. Asia Aquaporin Revenue Share by Region (2021-2032) Figure 50. Japan Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Aquaporin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Aquaporin Revenue Share by Type (2021-2032) Figure 58. SAMEA Aquaporin Revenue Share by Application (2021-2032) Figure 59. SAMEA Aquaporin Revenue Share by Country (2021-2032) Figure 60. Brazil Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Aquaporin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Aquaporin Antibody
  • Aquaporin Channel Blocker
  • Other
Applications
  • Purification Of Water
  • Research
  • Medicine
  • Other
Companies covered
  • Merck KGaA
  • Santa Cruz Biotechnology
  • Proteintech Group
  • Boster Biological Technology
  • Bio-Techne
  • Bio-Rad Laboratories
  • Alomone Labs
  • Abcam
  • Abbexa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Aquaporin Market by Type
  3. 1.2.1 Global Aquaporin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Anti-Aquaporin Antibody
  5. 1.2.3 Aquaporin Channel Blocker
  6. 1.2.4 Other
  7. 1.3 Aquaporin Market by Application
  8. 1.3.1 Global Aquaporin Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Purification Of Water
  10. 1.3.3 Research
  11. 1.3.4 Medicine
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Aquaporin Market Dynamics
  1. 2.1 Aquaporin Industry Trends
  2. 2.2 Aquaporin Industry Drivers
  3. 2.3 Aquaporin Industry Opportunities and Challenges
  4. 2.4 Aquaporin Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Aquaporin Market Perspective (2021-2032)
  2. 3.2 Global Aquaporin Growth Trends by Region
  3. 3.2.1 Global Aquaporin Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Aquaporin Market Size by Region (2021-2026)
  5. 3.2.3 Global Aquaporin Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Aquaporin Revenue by Players
  2. 4.1.1 Global Aquaporin Revenue by Players (2021-2026)
  3. 4.1.2 Global Aquaporin Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Aquaporin Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Aquaporin Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Aquaporin Key Players Headquarters & Area Served
  7. 4.4 Global Aquaporin Players, Product Type & Application
  8. 4.5 Global Aquaporin Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Aquaporin Market CR5 and HHI
  11. 4.6.3 2025 Aquaporin Tier 1, Tier 2, and Tier 3
5 Aquaporin Market Size by Type
  1. 5.1 Global Aquaporin Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Aquaporin Revenue by Type (2021-2032)
  3. 5.3 Global Aquaporin Revenue Market Share by Type (2021-2032)
6 Aquaporin Market Size by Application
  1. 6.1 Global Aquaporin Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Aquaporin Revenue by Application (2021-2032)
  3. 6.3 Global Aquaporin Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck KGaA
  2. 7.1.1 Merck KGaA Company Information
  3. 7.1.2 Merck KGaA Business Overview
  4. 7.1.3 Merck KGaA Aquaporin Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck KGaA Aquaporin Product Portfolio
  6. 7.1.5 Merck KGaA Recent Developments
  7. 7.2 Santa Cruz Biotechnology
  8. 7.2.1 Santa Cruz Biotechnology Company Information
  9. 7.2.2 Santa Cruz Biotechnology Business Overview
  10. 7.2.3 Santa Cruz Biotechnology Aquaporin Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Santa Cruz Biotechnology Aquaporin Product Portfolio
  12. 7.2.5 Santa Cruz Biotechnology Recent Developments
  13. 7.3 Proteintech Group
  14. 7.3.1 Proteintech Group Company Information
  15. 7.3.2 Proteintech Group Business Overview
  16. 7.3.3 Proteintech Group Aquaporin Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Proteintech Group Aquaporin Product Portfolio
  18. 7.3.5 Proteintech Group Recent Developments
  19. 7.4 Boster Biological Technology
  20. 7.4.1 Boster Biological Technology Company Information
  21. 7.4.2 Boster Biological Technology Business Overview
  22. 7.4.3 Boster Biological Technology Aquaporin Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Boster Biological Technology Aquaporin Product Portfolio
  24. 7.4.5 Boster Biological Technology Recent Developments
  25. 7.5 Bio-Techne
  26. 7.5.1 Bio-Techne Company Information
  27. 7.5.2 Bio-Techne Business Overview
  28. 7.5.3 Bio-Techne Aquaporin Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bio-Techne Aquaporin Product Portfolio
  30. 7.5.5 Bio-Techne Recent Developments
  31. 7.6 Bio-Rad Laboratories
  32. 7.6.1 Bio-Rad Laboratories Company Information
  33. 7.6.2 Bio-Rad Laboratories Business Overview
  34. 7.6.3 Bio-Rad Laboratories Aquaporin Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bio-Rad Laboratories Aquaporin Product Portfolio
  36. 7.6.5 Bio-Rad Laboratories Recent Developments
  37. 7.7 Alomone Labs
  38. 7.7.1 Alomone Labs Company Information
  39. 7.7.2 Alomone Labs Business Overview
  40. 7.7.3 Alomone Labs Aquaporin Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Alomone Labs Aquaporin Product Portfolio
  42. 7.7.5 Alomone Labs Recent Developments
  43. 7.8 Abcam
  44. 7.8.1 Abcam Company Information
  45. 7.8.2 Abcam Business Overview
  46. 7.8.3 Abcam Aquaporin Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Abcam Aquaporin Product Portfolio
  48. 7.8.5 Abcam Recent Developments
  49. 7.9 Abbexa
  50. 7.9.1 Abbexa Company Information
  51. 7.9.2 Abbexa Business Overview
  52. 7.9.3 Abbexa Aquaporin Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Abbexa Aquaporin Product Portfolio
  54. 7.9.5 Abbexa Recent Developments
8 North America
  1. 8.1 North America Aquaporin Revenue (2021-2032)
  2. 8.2 North America Aquaporin Revenue by Type (2021-2032)
  3. 8.2.1 North America Aquaporin Revenue by Type (2021-2026)
  4. 8.2.2 North America Aquaporin Revenue by Type (2027-2032)
  5. 8.3 North America Aquaporin Revenue Share by Type (2021-2032)
  6. 8.4 North America Aquaporin Revenue by Application (2021-2032)
  7. 8.4.1 North America Aquaporin Revenue by Application (2021-2026)
  8. 8.4.2 North America Aquaporin Revenue by Application (2027-2032)
  9. 8.5 North America Aquaporin Revenue Share by Application (2021-2032)
  10. 8.6 North America Aquaporin Revenue by Country
  11. 8.6.1 North America Aquaporin Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Aquaporin Revenue by Country (2021-2026)
  13. 8.6.3 North America Aquaporin Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Aquaporin Revenue (2021-2032)
  2. 9.2 Europe Aquaporin Revenue by Type (2021-2032)
  3. 9.2.1 Europe Aquaporin Revenue by Type (2021-2026)
  4. 9.2.2 Europe Aquaporin Revenue by Type (2027-2032)
  5. 9.3 Europe Aquaporin Revenue Share by Type (2021-2032)
  6. 9.4 Europe Aquaporin Revenue by Application (2021-2032)
  7. 9.4.1 Europe Aquaporin Revenue by Application (2021-2026)
  8. 9.4.2 Europe Aquaporin Revenue by Application (2027-2032)
  9. 9.5 Europe Aquaporin Revenue Share by Application (2021-2032)
  10. 9.6 Europe Aquaporin Revenue by Country
  11. 9.6.1 Europe Aquaporin Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Aquaporin Revenue by Country (2021-2026)
  13. 9.6.3 Europe Aquaporin Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Aquaporin Revenue (2021-2032)
  2. 10.2 China Aquaporin Revenue by Type (2021-2032)
  3. 10.2.1 China Aquaporin Revenue by Type (2021-2026)
  4. 10.2.2 China Aquaporin Revenue by Type (2027-2032)
  5. 10.3 China Aquaporin Revenue Share by Type (2021-2032)
  6. 10.4 China Aquaporin Revenue by Application (2021-2032)
  7. 10.4.1 China Aquaporin Revenue by Application (2021-2026)
  8. 10.4.2 China Aquaporin Revenue by Application (2027-2032)
  9. 10.5 China Aquaporin Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Aquaporin Revenue (2021-2032)
  2. 11.2 Asia Aquaporin Revenue by Type (2021-2032)
  3. 11.2.1 Asia Aquaporin Revenue by Type (2021-2026)
  4. 11.2.2 Asia Aquaporin Revenue by Type (2027-2032)
  5. 11.3 Asia Aquaporin Revenue Share by Type (2021-2032)
  6. 11.4 Asia Aquaporin Revenue by Application (2021-2032)
  7. 11.4.1 Asia Aquaporin Revenue by Application (2021-2026)
  8. 11.4.2 Asia Aquaporin Revenue by Application (2027-2032)
  9. 11.5 Asia Aquaporin Revenue Share by Application (2021-2032)
  10. 11.6 Asia Aquaporin Revenue by Country
  11. 11.6.1 Asia Aquaporin Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Aquaporin Revenue by Country (2021-2026)
  13. 11.6.3 Asia Aquaporin Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Aquaporin Revenue (2021-2032)
  2. 12.2 SAMEA Aquaporin Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Aquaporin Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Aquaporin Revenue by Type (2027-2032)
  5. 12.3 SAMEA Aquaporin Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Aquaporin Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Aquaporin Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Aquaporin Revenue by Application (2027-2032)
  9. 12.5 SAMEA Aquaporin Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Aquaporin Revenue by Country
  11. 12.6.1 SAMEA Aquaporin Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Aquaporin Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Aquaporin Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research